Looking Forward: 2026 Market Outlook and Research Directions Industry observers expect the probiotic GLP-1 supplement category to continue growing throughout 2026 as several factors converge: pharmaceutical GLP-1 pricing remains prohibitive for most Americans without comprehensive insurance coverage
The field of nutritional supplementation is continually evolving, and staying informed will help you make the best choices for your health
No microdose tiers, oral tablets, or liquid drops are available for either semaglutide or tirzepatide
The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
Pricing varies only by the treatment plan you select (4-, 12-, 24-, or 52-week plans), as shown during checkout
Decker Weiss, NMD, FASA